Providing Powerful Precision in Diagnosing Cancer for Patients

Hackensack Meridian Health recently announced JFK University Medical Center’s Laboratory Medical Director, Alex Ewing, M.D., as the Medical Director of the recently opened genomics sequencing laboratory, Anthology Diagnostics.

With more than 20 years of experience in pathology laboratory diagnostics and administration, Dr. Ewing brings strong leadership and deep knowledge in precision cancer testing to the Anthology Lab. He has been the medical director at Hackensack Meridian’s JFK University Medical Center since 2008, and will remain in that role as he takes on this new responsibility.

“I am proud to be part of the multi-talented team at Anthology Diagnostics. Hackensack Meridian Health is committed to apply the latest technologies in molecular diagnostics in order to refine our patients' treatments plans - and expand precision medicine at scale. This initiative puts us at the forefront of cancer care and research and I am thrilled to lead this effort." said Dr. Ewing.

The reference laboratory offers next generation sequencing data of DNA and RNA that helps clinicians in treatment decision-making for their patients, as well as to researchers seeking to identify innovative biomarkers that can further improve the understanding and management of blood cancers and solid tumors.

“The future of cancer care is very promising nowadays with an unprecedented number of novel therapies, but also as much so in diagnostics” said Andre Goy, MD, MS, physician-in-chief for Oncology at Hackensack Meridian Health. “Thanks to next generation sequencing and easier technology, in particular through liquid biopsies, the use of genomics has entered routine practice and it is becoming a natural expansion of pathology. Under Dr. Ewing’s leadership, our goal is to answer the most critical question for every cancer patient - what is my best option now? ”

Before his appointment at JFK University Medical Center, Dr. Ewing received his BS degree from Davidson College in 1993, and his MD degree from Wake Forest University School of Medicine in 1997. He completed his residency in Anatomic and Clinical Pathology at Georgetown University Hospital in Washington, DC in 2001, also serving as Chief Resident. Dr. Ewing completed a fellowship in Surgical Pathology at Georgetown in 2002, followed by a fellowship in Cytopathology at Memorial-Sloan Kettering Center in 2003. Dr. Ewing’s specific academic interests are in molecular pathology of adult brain tumors, breast cancer, and cytopathology.